Wells Fargo’s Regulus Therapeutics RGLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
|
|||||
2025
Q1 | $358K | Buy |
|
|||||
2024
Q4 | $55.6K | Buy |
|
|||||
2024
Q3 | $41.7K | Buy |
|
|||||
2024
Q2 | $46.1K | Buy |
|
|||||
2024
Q1 | $409 | Buy |
|
|||||
2023
Q4 | $180 | Buy |
|
|||||
2023
Q3 | $175 | Buy |
|
|||||
2023
Q2 | $187 | Buy |
|
|||||
2023
Q1 | $90 | Buy |
|
|||||
2022
Q4 | $126 | Buy |
|
|||||
2022
Q3 | $0 | Sell |
|
|||||
2022
Q2 | $1K | Sell |
|
|||||
2022
Q1 | $2K | Buy |
|
|||||
2021
Q4 | $2K | Sell |
|
|||||
2021
Q3 | $5K | Sell |
|
|||||
2021
Q2 | $6K | Buy |
|
|||||
2021
Q1 | $12K | Buy |
|
|||||
2020
Q4 | $10K | Sell |
|
|||||
2020
Q3 | $8K | Sell |
|
|||||
2020
Q2 | $12K | Sell |
|
|||||
2020
Q1 | $10K | Buy |
|
|||||
2019
Q4 | $14K | Sell |
|
|||||
2019
Q3 | $12K | Sell |
|
|||||
2019
Q2 | $21K | Sell |
|
|||||
2019
Q1 | $23K | Buy |
|
|||||
2018
Q4 | $16K | Sell |
|
|||||
2018
Q3 | $55K | Sell |
|
|||||
2018
Q2 | $248K | Sell |
|
|||||
2018
Q1 | $276K | Sell |
|
|||||
2017
Q4 | $407K | Sell |
|
|||||
2017
Q3 | $615K | Sell |
|
|||||
2017
Q2 | $688K | Sell |
|
|||||
2017
Q1 | $1.29M | Buy |
|
|||||
2016
Q4 | $1.55M | Buy |
|
|||||
2016
Q3 | $2.08M | Buy |
|
|||||
2016
Q2 | $1.48M | Buy |
|
|||||
2016
Q1 | $2.83M | Buy |
|
|||||
2015
Q4 | $2.38M | Buy |
|
|||||
2015
Q3 | $1.73M | Buy |
|
|||||
2015
Q2 | $2.74M | Buy |
|
|||||
2015
Q1 | $3.09M | Buy |
|
|||||
2014
Q4 | $2.76M | Sell |
|
|||||
2014
Q3 | $1.28M | Sell |
|
|||||
2014
Q2 | $1.67M | Buy |
|
|||||
2014
Q1 | $1.51M | Buy |
|
|||||
2013
Q4 | $885K | Buy |
|
|||||
2013
Q3 | $842K | Buy |
|
|||||
2013
Q2 | $442K | Buy |
|